drugset / Trial / NCT00703755
A Randomized, Double-Blind Trial Comparing the Efficacy and Safety of Fenofibrate, Metformin, Their Combination and Placebo in Patients With Metabolic Syndrome.
RandomizedFactorialDouble-blindTreatment
Summary
The purpose of this study was to study the effect of different combinations of fenofibrate and metformin on the cluster of metabolic syndrome (MetS) biochemical abnormalities, and to determine the dose combination allowing normalization of MetS patients.
Timeline
- Start
- 2003-03
- Primary completion
- 2004-06
- Completion
- 2004-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fenofibrate | Small molecule | 40 mg | — |
| Subject | Fenofibrate | Small molecule | 80 mg | — |
| Subject | Metformin | Small molecule | 500 mg | — |
| Subject | Metformin | Small molecule | 850 mg | — |